Clinical Trials
118 trialsNCT07252726 2026-05-27
Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
Ottawa Hospital Research Institute
Phase 4 Recruiting
NCT05348876 2026-05-18
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
Bayer
Phase 4 Recruiting
NCT06733350 2026-05-14
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Roswell Park Cancer Institute
Phase 4 Recruiting
NCT06604442 2026-05-12
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
Blue Earth Diagnostics
Phase 4 Completed
NCT04108208 2026-05-11
A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)
Janssen Research & Development, LLC
Phase 4 Active not recruiting
NCT07569926 2026-05-06
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Blue Earth Diagnostics
Phase 4 Not yet recruiting
NCT05753046 2026-04-23
TAPBlock
Corewell Health East
Phase 4 Enrolling by invitation
NCT05700903 2026-03-02
ARCH
University of Colorado, Denver
Phase 4 Completed
NCT03016741 2026-02-24
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
Northwestern University
Phase 4 Active not recruiting
NCT07278362 2026-02-23
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
University of Miami
Phase 4 Not yet recruiting
NCT06627530 2026-02-11
COAction
Brazilian Clinical Research Institute
Phase 4 Active not recruiting
NCT06099093 2026-01-29
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
Brigham and Women's Hospital
Phase 4 Recruiting
NCT04373564 2026-01-22
ODYSSEY
Guerbet
Phase 4 Recruiting
NCT06660862 2026-01-08
Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
University of Chicago
Phase 4 Not yet recruiting
NCT02651948 2025-12-19
Transperineal, MRI-guided, Prostate Biopsy
University Hospital, Strasbourg, France
Phase 4 Completed
NCT05722925 2025-11-14
Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET
OHSU Knight Cancer Institute
Phase 4 Active not recruiting
NCT06479187 2025-11-05
PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer
Brigham and Women's Hospital
Phase 4 Active not recruiting
NCT06226129 2025-10-20
Gadopiclenol in Contrast Enhanced MRI of the Prostate
Columbia University
Phase 4 Recruiting
NCT06074510 2025-09-11
MIRROR
Lantheus Medical Imaging
Phase 4 Active not recruiting
NCT06908694 2025-07-29
GAINPCCONTROL
Hamilton Health Sciences Corporation
Phase 4 Recruiting
NCT07001709 2025-06-03
ENABLE
Deventer Ziekenhuis
Phase 4 Recruiting
NCT05805436 2025-05-30
Preop Laxatives in Robotic Urologic Surgery
University of Iowa
Phase 4 Recruiting
NCT01673984 2025-05-23
GREAT
Ipsen
Phase 4 Terminated
NCT05803941 2025-04-24
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Novartis
Phase 4 Recruiting
NCT06784986 2025-01-20
ARCO2
Brazilian Institute of Robotic Surgery
Phase 4 Recruiting
NCT04134208 2025-01-16
An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT05568537 2025-01-03
Prostate MRI and Pylarify PSMA PET/CT
Corewell Health East
Phase 4 Withdrawn
NCT02918968 2024-12-09
Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer
Astellas Pharma Inc
Phase 4 Completed
NCT06706921 2024-11-27
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
VA Greater Los Angeles Healthcare System
Phase 4 Recruiting
NCT03035032 2024-11-26
A Study of ELIGARDĀ® in Hormone-dependent Prostate Cancer Patients
Astellas Pharma Inc
Phase 4 Completed
NCT05629494 2024-10-18
ADAPT-PSA
Albany Medical College
Phase 4 Recruiting
NCT01794793 2024-10-01
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
RECORDATI GROUP
Phase 4 Completed
NCT00953277 2024-08-12
Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer
Axogen Corporation
Phase 4 Completed
NCT05957822 2024-05-14
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery
Konkuk University Medical Center
Phase 4 Recruiting
NCT06258486 2024-02-26
Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks
Kaiser Permanente
Phase 4 Unknown
NCT05803096 2024-01-30
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
Beth Israel Deaconess Medical Center
Phase 4 Completed
NCT03432949 2024-01-24
TRANCE
University Health Network, Toronto
Phase 4 Unknown
NCT06144099 2024-01-02
Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgery
Konkuk University Medical Center
Phase 4 Unknown
NCT03824808 2023-10-25
Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery
University of Missouri-Columbia
Phase 4 Terminated
NCT01995513 2023-09-18
PLATO
Pfizer
Phase 4 Completed
NCT06001619 2023-08-21
PROMED
Turku University Hospital
Phase 4 Recruiting
NCT05957653 2023-07-24
Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort
RenJi Hospital
Phase 4 Unknown
NCT03796195 2023-01-25
(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes
Northwestern University
Phase 4 Terminated
NCT05631080 2022-11-30
Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer
Mansoura University
Phase 4 Unknown
NCT04074460 2022-06-09
VAPOR-C
Peter MacCallum Cancer Centre, Australia
Phase 4 Completed
NCT03228108 2022-05-10
pro-SWAP
Radboud University Medical Center
Phase 4 Completed
NCT05304169 2022-03-31
PRIZE
Zodiac Produtos Farmaceuticos S.A.
Phase 4 Completed
NCT02726009 2021-12-15
A Trial to Evaluate Safety of FirmagonĀ® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer
Ferring Pharmaceuticals
Phase 4 Completed
NCT05068180 2021-10-06
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients
RenJi Hospital
Phase 4 Unknown
NCT04248621 2021-07-29
Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients
Wonju Severance Christian Hospital
Phase 4 Unknown